Nuvalent, Inc. (NUVL)

Jul 15, 2026 - NUVL was delisted (reason: acquired by GSK)

123.96

+0.02 (0.02%)

Inactive · Last trade price on Jul 14, 2026

Nuvalent Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	159.73	261.75	145.69	335.39	241.81	68.53
Short-Term Investments	1,128	1,110	972.61	384.52	230.36	219.59
Cash & Short-Term Investments	1,287	1,372	1,118	719.91	472.16	288.11
Cash Growth	19.96%	22.68%	55.34%	52.47%	63.88%	2688.53%
Other Current Assets	20.46	20.47	14.15	6.58	5.83	2.52
Total Current Assets	1,308	1,392	1,132	726.49	477.99	290.63
Other Long-Term Assets	23.21	20.28	9.3	5.9	4.47	3.2
Total Assets	1,331	1,413	1,142	732.38	482.46	293.82

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	22.14	30.16	5.23	9.27	7.2	2.89
Accrued Expenses	58.92	61.01	48.8	22.55	12.29	5.89
Total Current Liabilities	81.05	91.17	54.02	31.82	19.48	8.79
Other Long-Term Liabilities	75.73	73.2	17.94	-	-	-
Total Long-Term Liabilities	75.73	73.2	17.94	-	-	-
Total Liabilities	156.78	164.37	71.96	31.82	19.48	8.79

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.01	0.01	0.01	0.01	0	0.01
Additional Paid-in Capital	2,257	2,218	1,617	986.82	623.54	363.48
Accumulated Other Comprehensive Income	-1.36	2.35	-0.06	0.03	-0.49	-0.23
Retained Earnings	-1,082	-972.43	-547.05	-286.3	-160.08	-78.22
Total Common Shareholders' Equity	1,174	1,248	1,070	700.56	462.97	285.04
Shareholders' Equity	1,174	1,248	1,070	700.56	462.98	285.04
Total Liabilities & Equity	1,331	1,413	1,142	732.38	482.46	293.82

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Cash (Debt)	1,287	1,372	1,118	719.91	472.16	288.11
Net Cash Growth	19.96%	22.68%	55.34%	52.47%	63.88%	2688.53%
Net Cash Per Share	17.30	18.88	16.84	12.37	9.51	13.23
Book Value	1,174	1,248	1,070	700.56	462.97	285.04
Book Value Per Share	15.78	17.17	16.11	12.03	9.32	13.08
Tangible Book Value	1,174	1,248	1,070	700.56	462.97	285.04
Tangible Book Value Per Share	15.78	17.17	16.11	12.03	9.32	13.08

SEC Filings: 10-K · 10-Q